Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) developed at the University of Arizona. It is a non-selective melanocortin receptor agonist with high affinity for MC1R, MC3R, MC4R, and MC5R.
Melanocortin Receptor Pharmacology Research
Preclinical pharmacology research has characterized Melanotan II's binding affinities and functional activities across the melanocortin receptor family. Studies have examined its interactions with MC1R in melanocyte models and the intracellular signaling cascades it activates in receptor expression systems.
Pigmentation Pathway Research
Research in melanocyte cell culture models has examined Melanotan II's effects on melanogenesis signaling, including its activation of the MC1R-cAMP-MITF-tyrosinase pathway and its effects on melanosome production in experimental pigmentation models.
Central Nervous System and Autonomic Research
A significant body of preclinical research has examined Melanotan II's central nervous system effects mediated through MC4R, which is expressed in hypothalamic and brainstem nuclei involved in autonomic nervous system regulation and energy balance signaling.
• Hruby VJ et al. (1987). Cyclic lactam analogues of alpha-melanotropin. Journal of Medicinal Chemistry, 30(4), 640–645.
